Ultragenyx Pharmaceutical Inc. (RARE) scores 34 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $-56.98, representing a 64% margin of safety.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.